Anonymize PHI amendment request documentation for internal review – CCPA/HIPAA-compliant de-identification per 45 CFR §164.526
Under 45 CFR §164.526, individuals may request amendments to their PHI in a covered entity's designated record set. Amendment request files — which include the original disputed records, the patient's written request, and any supporting clinical documentation — contain concentrated PHI. anonym.legal de-identifies these files for internal quality-improvement analysis and legal process documentation without exposing individual patient data.
When this applies
Apply this workflow when amendment request files are reviewed by a quality-improvement committee, shared with outside counsel for litigation involving the amendment process, or used to train staff on amendment procedures, and the reviewers do not require identifiable patient data.
How anonym.legal handles it
- Upload the amendment request package — the patient's written request, the disputed record section, and the covered entity's response — to anonym.legal.
- The engine identifies PHI across all documents: patient name, MRN, date of birth, contact details, and clinical content identifiers.
- All 18 Safe Harbor identifiers are removed from both the disputed records and the procedural correspondence.
- The factual basis of the amendment request — the clinical statement disputed, the supporting evidence provided, and the entity's acceptance or denial decision — is preserved in de-identified form.
- Denial reasons documented under §164.526(d)(1) are preserved verbatim as procedural content.
- The de-identified package is delivered for internal review or external legal use.
What you provide
- Patient's written amendment request
- The disputed PHI record or section
- Covered entity's written response to the amendment request
Limitations & cautions
- Amendment requests involving highly specific clinical disputes may remain re-identifying even after Safe Harbor de-identification; manual review is recommended before sharing with parties outside the covered entity.
- Under §164.526(c)(1), covered entities must act on amendment requests within 60 days; de-identification for internal review purposes must not delay this obligation.
- The tool de-identifies the documentary record but does not evaluate the merits of the amendment request — clinical and legal review of the substance is required separately.
FAQ
What grounds can a covered entity use to deny an amendment request?
Under §164.526(d), a covered entity may deny an amendment request if the PHI was not created by the covered entity, is not part of the designated record set, is accurate and complete, or would not be available for inspection under §164.524. The denial must be in writing and include information about how the individual may submit a statement of disagreement.
Must the covered entity accept the amendment if the patient provides clinical evidence?
The covered entity has discretion to evaluate the evidence. If it accepts the amendment, it must make the amendment to the designated record set under §164.526(c)(1) and notify relevant parties who received the information. Acceptance is not automatic upon submission of supporting evidence.
Are statements of disagreement submitted by patients de-identified separately?
Yes. Statements of disagreement filed by patients under §164.526(b)(2) are part of the designated record set. The engine processes them in the same workflow batch, de-identifying identifiers while preserving the substantive dispute narrative.